The Gates Foundation and OpenAI's $50 million Horizon 1000 initiative aims to deploy AI diagnostic tools to 1,000

Healthcare's AI ambitions are colliding with practical realities. With 62% of leaders citing fragmented data as their primary

After years of cautious skepticism, physicians and healthcare leaders are reaching consensus: AI's benefits in clinical settings now

The Bristol Myers Squibb-Microsoft collaboration to develop AI-powered lung cancer detection tools signals a fundamental shift in pharmaceutical

OpenAI and Anthropic have launched competing healthcare AI products—ChatGPT Health and Claude for Healthcare—marking a strategic battle for

Healthcare's most prominent voices are converging on a striking consensus: AI adoption is essential for system survival. From

The AI medical imaging market is transitioning from experimental deployments to an $8.5+ billion industry by 2030. With

The FDA's 2026 AI guidance introduces flexible oversight for medical AI devices, sparking debate about innovation versus patient

The 2026 J.P. Morgan Healthcare Conference revealed a decisive shift in how the industry approaches artificial intelligence. No

Artificial intelligence is transforming oncology through dual capabilities: mapping population-level cancer survival patterns to reveal systemic inequities, and